Product logins

Find logins to all Clarivate products below.


Aesthetic Injectables | Market Insights | Latin America (Supplemental) | 2025

The Latin American aesthetic injectable market will show strong growth through 2033. Market expansion will be supported by product development and differentiation efforts from market players, as well as the emergence of more affordable products that offer similar efficacy to premium brands from the leading competitors. Medical tourism in the region will also contribute to increasing demand for aesthetic injectables; however, growth will gradually decelerate as the market continues to mature.

This Medtech 360 Report provides high-level market metrics for aesthetic injectables in Latin America, including country-level data for major countries and aggregate data for the rest of the Latin America from 2019 through 2033.

Related Medtech Insights Reports

Report
Aesthetic Injectables – Market Insights – Middle East
The Middle Eastern aesthetic injectable market will see strong growth, driven by the rising awareness and acceptability of these procedures due to the growing influence of social media, as well as…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectables market will expand through 2035, driven by ongoing product innovation and differentiation strategies among key competitors, as well as the increasing…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…